Skip to main content

We deliver.

Natural delivery to unlock the full potential of cell and gene therapies

Our delivery platform
We deliver
Patient on treatment

Our delivery platform

Imagine a world where we conquer cancer and genetic diseases.
At NTrans, we solve key challenges in cell and gene therapy:
Delivering life-changing therapies to the right cells and tissues.

Discover more

Quick facts

Non-viral delivery

Natural uptake mechanism

High gene editing efficiency

High cell viability

Excellent intrinsic safety

Simple implementation

Low manufacturing costs

High scalability

Mission statement

About us
Nuclear transport

Opportunities

CAR-T

CRISPR/Cas9

Base editors

Prime editors

News

February 1, 2024 in News

New branding and website

Launch of the new branding and website.
Read More
December 12, 2023 in News

Health Holland non-dilutive funding awarded

NTrans joins the Dutch Life Science Conference 7 December 2023, Corpus Leiden.
Read More
December 7, 2023 in News

Dutch Life Science Conference

NTrans joins the Dutch Life Science Conference 7 December 2023, Corpus Leiden.
Read More
August 1, 2023 in News

Ester Weijers new CEO NTrans

New CEO joins NTrans Technologies, Ester Weijers, PhD. “At NTrans Technologies, we embrace the power of science and technology to uplift lives. As CEO, I am privileged to guide our…
Read More
June 1, 2023 in News

MIT Feasibility study awarded

Read More
March 9, 2023 in News

H2020 iPSPine consortium

NTrans participates in the H2020 iPSPine consortium meeting in Rome.
Read More